Patent Assignment
Reel/Frame 062282/0787
Assignment of Assignor's Interest
Recorded: 2023-01-05
Pages: 8
Assignor
DNA-SEQ, INC.
Executed: 2022-12-19
Assignee
DNA SEQ 2, INC.
3210 MERRYFIELD ROW, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(7)
Method and System for Determination of an Effective Protein Kinase Inhibitor
Application:
61/932,156 →
Methods and Systems for Determination of an Effective Therapeutic Regimen and Drug Discovery
Methods and Systems for Determination of an Effective Therapeutic Regimen and Drug Discovery
Methods and Systems for Determination of an Effective Therapeutic Regimen and Drug Discovery
Methods and Systems for Determination of an Effective Therapeutic Regimen and Drug Discovery
Application:
16/866,281 →
Publication:
US 2020/0332369
Methods and Systems for Determination of an Effective Therapeutic Regimen and Drug Discovery
Application:
17/921,477 →
Publication:
US 2023/0183810
Methods and Systems for Determination of an Effective Therapeutic Regimen an Drug Discovery
PCT:
PCT/US2015/013133 ↗
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 5, 2014
From: SOWADSKI, JANUSZ; MOIANI, DAVIDE
To: DNA-SEQ, INC.
Reel/Frame 032143/0771 →
Assignment of Assignor's Interest
May 11, 2018
From: MOIANI, DAVIDE; SOWADSKI, JANUSZ
To: DNA-SEQ, INC.
Reel/Frame 045778/0198 →
Assignment of Assignor's Interest
Feb 7, 2019
From: SOWADSKI, JANUSZ
To: DNA-SEQ, INC.
Reel/Frame 048272/0023 →
Assignment of Assignor's Interest
May 4, 2020
From: SOWADSKI, JANUSZ
To: DNA-SEQ, INC.
Reel/Frame 052564/0898 →
Assignment of Assignor's Interest
Oct 27, 2025
From: SOWADSKI, JANUSZ
To: DNA-SEQ, INC.
Reel/Frame 072690/0938 →